Sign in

CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Definium Therapeutics, Inc.

Sign in to watch
Ticker
DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
212-220-6633
Business address
ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
Former names
Mind Medicine (MindMed) Inc.
  1. 4 Shares withheld for taxes Executive President gave up 32,595 shares (to pay taxes)
  2. 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $6.22 ($6,215)
  3. 4 Planned sale Chief Medical Officer sold 6,925 shares at $7.22 ($49,999)
  4. 4 Planned sale Chief Legal Officer sold 17,854 shares at $7.22 ($128,906)
  5. 4 Planned sale Chief Executive Officer sold 15,659 shares at $7.22 ($113,058)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 5,560 shares (to pay taxes)
  12. 4 Planned sale Chief Medical Officer sold 6,578 shares at $9.50 ($62,491)
  13. 4 Planned sale Chief Executive Officer sold 16,519 shares at $9.50 ($156,931)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Chief Medical Officer sold 6,774 shares at $3.63 ($24,590)

Page 5 of 10 · 186 filings